Though CRP and AGP are often measured in health surveys (64, 65), different biomarkers, such as the APP IL-6 or the hepatic hormone hepcidin, have also been reported as being elevated among individuals with obesity (57, 62), and their inclusion may help further characterize the relationships between iron status markers and inflammation. Here, HAMP is linked to obesity disorder.